A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

PHASE3CompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Gastroesophageal Reflux
Interventions
DRUG

Dexlansoprazole

30 mg capsule, orally, once daily for 4 weeks

DRUG

Placebo

1 capsule, orally, once daily for 4 weeks

Trial Locations (43)

Unknown

Tucson

Anaheim

Garden Grove

Lancaster

Oakland

San Diego

Sherwood

Westlake Village

Jupiter

Miami

New Smyrna Beach

Ocala

St. Petersburg

Zephyrhills

Moline

Clive

Wichita

Metairie

Prince Frederick

Jefferson City

Egg Harbor Town

Great Neck

Greensboro

Harrisburg

Winston-Salem

Mogadore

Oklahoma City

Portland

Duncansville

Bristol

Chattanooga

Johnson City

Kingsport

Nashville

El Paso

Fort Worth

Houston

Odessa

San Antonio

Ogden

Norfolk

Spokane

Monroe

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY